Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 112 of 1,261
  1. CA 3256311

    MÉTHODES D'AMÉLIORATION DE LA SANTÉ OSSEUSE AU MOYEN DE PRODUITS ENRICHIS EN EXOSOMES DE LAIT BOVIN ET DE VITAMINE K2

    ABBOTT LAB [US] · Granted Jun 13, 2024 · Expires Jun 8, 2044

    granted
  2. US 12005127

    DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  3. US 12006321

    Substituted pyrazolo[1,5-a]pyrimidines as apelin receptor agonists

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  4. US 12005081

    Chimeric receptors and methods of use thereof

    Senti Biosciences, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  5. US 12006329

    Protein degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  6. US 12005052

    Topical roflumilast formulation having improved delivery and plasma half-life

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  7. US 12005115

    Epstein-barr virus vaccines

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  8. US 12005060

    Ophthalmic formulations of methotrexate

    Aldeyra Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  9. US 12005055

    Methods for shrinking pituitary tumors

    Corcept Therapeutics Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  10. US 12005126

    Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption

    ALMIRA PHARMA SRL · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  11. US 12005123

    Conjugate of isotretinoin and peptide

    CAREGEN CO., LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  12. US 12005066

    Cobinamide compounds as a cyanide, sulfide, or methane-thiol antidote

    The Regents of the University of California · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  13. US 12006294

    Therapeutic compounds

    Regents of the University of Minnesota · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  14. US 12005074

    Extrahepatic delivery

    Alnylam Pharmaceuticals, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  15. US 12006298

    Polymorphic compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  16. US 12005220

    Microneedle patch for immunostimulatory drug delivery

    Veradermics Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  17. US 12005194

    Configurable oxygen concentrator and related method

    SEPARATION DESIGN GROUP LLC · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  18. US 12006364

    Anti-CD100 antibodies and methods for using the same

    VACCINEX, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  19. US 12005139

    Ophthalmic formulations and related methods

    ETERNATEAR, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  20. US 12006517

    Method for purification of bacteriophage particles

    Adaptive Phage Therapeutics, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  21. US 12006365

    Human anti-semaphorin 4D antibody

    VACCINEX, INC. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  22. US 12006516

    Differentiation of pancreatic endocrine cells

    Vertex Pharmaceuticals Incorporated · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  23. US 12005036

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted
  24. US 12006348

    T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereof

    Cue Biopharma, Inc. · Granted Jun 11, 2024 · Expires Jun 6, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.